Founded in 1946 in Bergamo (Lombardia) by the Donati family as a laboratory for the manufacturing of medicinal products, O.F.I. Officina Farmaceutica Italiana is nowadays active mainly as a CMO (Contract Manufacturing Organization) in the dermo-cosmetic and food supplementing sectors.
Company’s key assets are the focus on innovation, product excellence, customer care and utmost attention to regulatory aspects, which allowed OFI to establish itself among the main players in the market.
OFI supports its customers in each different step of product development, from formulation and feasibility study to full-service contract manufacturing, an offer underpinned by a high production flexibility as well as by a reduced time-to-market.
In December 2020 the company was sold to a trade buyer owned by a pan-European Private Equity group.